Atara Biotherapeutics, Inc. (ATRA)
13.67
-3.77
(-21.62%)
USD |
NASDAQ |
Jan 09, 16:00
13.65
-0.02
(-0.15%)
After-Hours: 20:00
Atara Biotherapeutics EPS Diluted (Quarterly): -0.3172 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pacira Biosciences, Inc. | 0.1222 |
| ADMA Biologics, Inc. | 0.1489 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.303M |
| Revenue (Quarterly) | 3.453M |
| Total Expenses (Quarterly) | 7.756M |
| Enterprise Value | 143.46M |
| Gross Profit Margin (Quarterly) | 96.67% |
| Profit Margin (Quarterly) | -124.6% |
| Earnings Yield | 16.04% |
| Operating Earnings Yield | 23.19% |
| Normalized Earnings Yield | 21.31 |